e-learning
resources
London 2016
Monday, 05.09.2016
Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m
Michael Furian (Zurich, Switzerland), Michael Furian, Mona Lichtblau, Sayaka S. Aeschbacher, Maya Bisang, Alexey Nikiforov, Tsogyal D. Latshang, Silvia Ulrich, Almaz Aldashev, Talant Sooronbaev, Konrad E. Bloch
Source:
International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Session:
Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Session type:
Thematic Poster
Number:
2392
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Michael Furian (Zurich, Switzerland), Michael Furian, Mona Lichtblau, Sayaka S. Aeschbacher, Maya Bisang, Alexey Nikiforov, Tsogyal D. Latshang, Silvia Ulrich, Almaz Aldashev, Talant Sooronbaev, Konrad E. Bloch. Effect of dexamethasone on nocturnal breathing in lowlanders with COPD travelling to 3200m. Eur Respir J 2016; 48: Suppl. 60, 2392
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Breathing and sleep disturbances in lowlanders with COPD travelling to 2590m
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015
Cerebral oxygenation in lowlanders with COPD spending a night at 2590m
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Effect of travelling to 2590m on 6-minute walk distance, blood gases and symptoms of acute mountain sickness in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Cerebral oxygen availability limits exercise performance of lowlanders with chronic obstructive pulmonary disease (COPD) travelling to 2590m
Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease
Year: 2015
Effects of acetazolamide on sleep disordered breathing in patients with COPD staying at high altitude. RCT.
Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects
Year: 2019
Postural control in COPD patients travelling from 760 m to 3200 m; randomized trial evaluating effects of dexamethasone
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016
Nocturnal and exercise oxygen desaturation in COPD patients with and without OSAS
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013
Altitude related adverse health effects in lowlanders with COPD travelling to 3200m
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016
Effect of nocturnal oxygen therapy on daytime pulmonary hemodynamics in patients with COPD travelling to altitude. RCT.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021
Nocturnal hypoxemia and depression among out-patients COPD subjects: A case-control study
Source: International Congress 2014 – Evaluating sleep disordered breathing in children and adults
Year: 2014
Effects of 1 year of treatment with nocturnal CPAP in overlap syndrome
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015
Does 6 minute walk test predict nocturnal oxygen desaturation in COPD patients?
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Sleep and breathing in COPD: does nocturnal O2 or NIV decrease mortality?
Source: ERS Conference
Year: 2015
Late Breaking Abstract - Effect of oxygen supplementation on sleep and nocturnal breathing in patients with chronic obstructive pulmonary disease travelling to high altitude: randomized trial
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018
Effect of dexamethasone prophylaxis on sleep and breathing disturbances in high altitude pulmonary edema (HAPE) susceptible subjects after rapid ascent to 4559m
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010
Tiotropium respimat versus HandiHaler to improve sleeping oxygen saturation and sleep quality in COPD
Source: International Congress 2014 – Evaluating sleep disordered breathing in children and adults
Year: 2014
Retrospective analysis of oxygen therapy in persistent nocturnal hypoxia despite CPAP in obstructive sleep apnoea syndrome (OSAS)
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014
Long term use of CPAP therapy improves asthma's outcome in patients with asthma and sleep apnoea
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014
Effect of auto-CPAP therapy on parameters of rhinomanometry in patients with COPD combined with OSAHS
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Effect of cold stimulation over face on 6 minute walk distance (6MWD), oxygen saturation and dyspnea scores in patients with COPD
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept